简介:
Overview
This protocol describes a time-specific method for manipulating critical developmental pathways in the mouse placenta using CRISPR. The technique involves the injection and electroporation of CRISPR plasmids into the placentas of pregnant mice at embryonic day 12.5.
Key Study Components
Area of Science
- Neuroscience
- Developmental Biology
- Genetic Engineering
Background
- Targeted manipulation of gene functions during pregnancy is crucial for understanding developmental processes.
- Genetic modifications in the placenta are rare and challenging.
- This method allows for a range of gene expression changes.
- Mastery of the technique requires practice and persistence.
Purpose of Study
- To elucidate specific gene functions during mid to late pregnancy.
- To provide a reliable method for gene manipulation in the mouse placenta.
- To advance the understanding of placental development and function.
Methods Used
- Injection of CRISPR plasmids into mouse placentas.
- Electroporation to facilitate plasmid uptake.
- Timing of intervention at embryonic day 12.5.
- Assessment of gene expression changes post-manipulation.
Main Results
- Successful manipulation of gene expression in the mouse placenta.
- Demonstrated potential for overexpression of specific genes.
- Provided insights into the challenges and learning curve associated with the technique.
- Highlighted the significance of time-specific interventions.
Conclusions
- This method represents a significant advancement in placental research.
- It opens new avenues for studying gene function during pregnancy.
- Researchers are encouraged to persist through initial challenges.
What is the significance of this protocol?
It allows for targeted manipulation of mouse placentas using CRISPR, aiding in the study of gene functions during pregnancy.
What challenges might researchers face?
The technique is challenging and may require time to master, with initial attempts possibly being unsuccessful.
At what embryonic stage is the intervention performed?
The intervention is performed on embryonic day 12.5.
What are the main advantages of this method?
It allows for a range of gene expression changes within the placenta, which is uncommon in existing techniques.
How can researchers improve their success with this technique?
Practice and persistence are key; researchers should not be discouraged by initial failures.